• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adverse events following vaccine or placebo injection in an efficacy trial of an outer membrane vesicle vaccine against group B meningococcal disease in Norwegian secondary schools 1988-1991.

作者信息

Aavitsland P, Bjune G, Aasen S, Halvorsen S

机构信息

Department of Infectious Disease Control, National Institute of Publich Health, Oslo.

出版信息

NIPH Ann. 1991 Dec;14(2):133-4; discussion 136-7.

PMID:1812426
Abstract
摘要

相似文献

1
Adverse events following vaccine or placebo injection in an efficacy trial of an outer membrane vesicle vaccine against group B meningococcal disease in Norwegian secondary schools 1988-1991.1988 - 1991年在挪威中学进行的一项针对B群脑膜炎球菌病的外膜囊泡疫苗效力试验中，接种疫苗或安慰剂后的不良事件。
NIPH Ann. 1991 Dec;14(2):133-4; discussion 136-7.
2
Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.挪威一项针对B群脑膜炎球菌病全身性疾病的外膜囊泡疫苗疗效试验的结果。
NIPH Ann. 1991 Dec;14(2):125-30; discussion 130-2.
3
The meningococcal serogroup B vaccine protection trial in Norway 1988-1991: trial surveillance by an independent group.1988 - 1991年挪威B群脑膜炎球菌疫苗保护试验：由独立小组进行的试验监测
NIPH Ann. 1991 Dec;14(2):135-6; discussion 136-7.
4
The Norwegian meningococcal group B outer membrane vesicle vaccine: side effects in phase II trials.挪威B群脑膜炎球菌外膜囊泡疫苗：II期试验中的副作用
NIPH Ann. 1991 Dec;14(2):95-101; discussion 101-2.
5
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.接种挪威B群脑膜炎球菌外膜囊泡疫苗后的杀菌抗体：简要调查
NIPH Ann. 1991 Dec;14(2):147-55; discussion 155-6.
6
Diagnostic work with suspected cases of systemic meningococcal disease in the Norwegian serogroup B vaccine protection trials.挪威B群脑膜炎球菌疫苗保护试验中疑似系统性脑膜炎球菌病病例的诊断工作。
NIPH Ann. 1991 Dec;14(2):103-6; discussion 121-3.
7
Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.挪威针对B群脑膜炎球菌病全身性疾病的外膜囊泡疫苗的临床试验设计。
NIPH Ann. 1991 Dec;14(2):81-91; discussion 91-3.
8
Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.抗B群脑膜炎奈瑟菌疫苗：古巴的保护试验和大规模疫苗接种结果
NIPH Ann. 1991 Dec;14(2):195-207; discussion 208-10.
9
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.B群脑膜炎球菌疫苗“Folkehelsa”的生产、特性及控制：一种针对B群脑膜炎球菌病的外膜囊泡疫苗
NIPH Ann. 1991 Dec;14(2):67-79; discussion 79-80.
10
Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.智利B群脑膜炎球菌疫苗保护试验及随访研究。智利国家脑膜炎球菌病委员会。
NIPH Ann. 1991 Dec;14(2):211-2; discussion 213.

引用本文的文献

1
Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.健康成人鼻内接种蛋白酶体-福氏志贺菌2a脂多糖疫苗的安全性和免疫原性。
Infect Immun. 2001 Jul;69(7):4545-53. doi: 10.1128/IAI.69.7.4545-4553.2001.